Log In
BCIQ
Print this Print this
 

Debio 1142

  Manage Alerts
Collapse Summary General Information
Company Debiopharm Group
DescriptionCancer pathway inhibitor
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentDiscovery
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
PartnerAurigene Discovery Technologies Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/14/2011

Undisclosed

Undisclosed

Undisclosed

03/01/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today